Investment
Features
FeesSafety
Academy
More
Pluang+

Strategy Inc. sells $104M Bitcoin to fund STRC preferred stock amid price target concerns

Market News
04 Aug 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Michael Saylor's Strategy Inc. sold $104 million in Bitcoin last week to finance STRC, a variable-rate perpetual preferred stock linked to Bitcoin purchases. This sale reflects Strategy's shift from holding Bitcoin indefinitely to using sales as part of capital-market financing. Market sentiment shows uncertainty about STRC reaching its $100 target price by year-end, with a 43.5% probability. Investors will watch for further Strategy announcements on Bitcoin purchases or STRC dividend changes that could impact STRC's market value.

More News

LivaNova price target raised after strong Q2 revenue and EPS beat, signaling growth in medical tech.

LivaNova price target raised after strong Q2 revenue and EPS beat, signaling growth in medical tech.

LivaNova's stock price target was raised to $85 following a strong Q2 performance with record revenue of $390.6 million, up 9.8%, and adjusted EPS of $1.26, beating estimates by 16.67%. The growth was driven by its Cardiopulmonary and Epilepsy segmen...

Company Fundamentals
Bullish
35 minutes ago
Glencore reports strong Q2 earnings, boosts shareholder returns with $1.5B cash and buyback

Glencore reports strong Q2 earnings, boosts shareholder returns with $1.5B cash and buyback

Glencore PLC reported better-than-expected Q2 results with earnings per share of $0.37 and revenue of $174.43 billion, driven by strong performance in its marketing and industrial divisions. Adjusted EBITDA surged to $10.11 billion, reflecting robust...

Company Fundamentals
Bullish
56 minutes ago
Cloudflare earnings preview: strong AI-driven growth but high valuation raises concerns

Cloudflare earnings preview: strong AI-driven growth but high valuation raises concerns

Cloudflare is set to report quarterly earnings with analysts expecting $0.27 EPS and $664.67 million revenue, reflecting strong growth driven by AI and edge computing innovations. Despite robust 31.55% revenue growth and 73% gross margins, the compan...

Company Fundamentals
Neutral
59 minutes ago
Supernus Pharmaceuticals posts negative ROIC, underperforming its cost of capital and peers.

Supernus Pharmaceuticals posts negative ROIC, underperforming its cost of capital and peers.

Supernus Pharmaceuticals reports a negative Return on Invested Capital (ROIC) of -9.12%, which is well below its Weighted Average Cost of Capital (WACC) of 6.92%. This indicates the company is not generating enough returns to cover its capital costs,...

Market News
Bearish
59 minutes ago
Wingstop's ROIC of 25.05% far exceeds its WACC of 10.18%, showing strong capital efficiency.

Wingstop's ROIC of 25.05% far exceeds its WACC of 10.18%, showing strong capital efficiency.

Wingstop Inc. demonstrates strong capital efficiency with a Return on Invested Capital (ROIC) of 25.05%, significantly higher than its Weighted Average Cost of Capital (WACC) of 10.18%. This results in an ROIC to WACC ratio of 2.46, indicating excell...

Market News
Bullish
59 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App